Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2009 Nov 22;55(1):50–60. doi: 10.1053/j.ajkd.2009.08.019

Table 2.

Laboratory results: Pre- and Post-treatment

Pt ID SCr (mg/dL) GFRe (mL/min/1.73 m2) urine protein-creatinine
ratio (mg/mg)
Albumin (g/dL)
Pre Post Pre Post Pre Post Pre Post
1 0.6 0.7 174 152 9.2 14 2.4 1.7
2 0.6 0.8 204 152 20 22 2.1 1.1
3 0.6 0.5 144 173 18 20 1.3 1.3
4 1.2 1.4 72 62 2.0 5.0 4.3 3.7
5 0.7 0.8 89 79 15 6.9 1.5 1.7
6 1.0 1.3 66 51 37 29 1.0 1.3
7 1.1 1.2 88 66 9.1 4.4 2.7 3.3
8 0.8 0.4 62 173 17 0.6 1.5 3.8
9 1.3 1.3 71 74 11.1a 6.7 1.8 1.6
10 1.0 1.0 85 84 3.6a 0.6 3.1 3.3
MEAN 0.9 0.9 105 106 15.9 10.9 2.1 2.3
SD 0.3 0.4 50 50 10.4 9.8 1.0 1.1
P value 0.9 0.9 0.3 0.7
a

Level of proteinuria was measured at the Screening Visit, study week -2

Conversion factors for units: serum creatinine in mg/dL to mmol/L, ×88.4; albumin in g/dL to g/L, ×10; eGFR in mL/min/1.73 m^2 to mL/s/1.73 m^2, ×0.01667.